These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7164161)

  • 21. Lymphoma and behavioral responses to psychomotor drugs.
    Lang JM; Vredevoe DL; Levy L
    Proc West Pharmacol Soc; 1984; 27():455-60. PubMed ID: 6494184
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physical factors in animal experiments for testing antimasspsychotic drugs].
    Asteridis H; Beckmann P; Diotinsky I
    Arzneimittelforschung; 1975 Sep; 25(9):1463-5. PubMed ID: 1242672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological activity of paramagnetic models of several psychotropic compounds and their derivatives].
    Lavretskaia EF; Zhdanov RI; Kapitanova NG; Volkova LN; Moshkovski IuSh
    Dokl Akad Nauk SSSR; 1978; 239(2):493-6. PubMed ID: 648313
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential drug effects as a function of the controlling consequences.
    Barrett JE
    NIDA Res Monogr; 1981 Jul; 37():159-81. PubMed ID: 6798457
    [No Abstract]   [Full Text] [Related]  

  • 25. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
    Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
    J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating use of psychotropic drugs with environmental management and behavioral modification for treatment of problem behavior in animals.
    Hart BL; Cooper LL
    J Am Vet Med Assoc; 1996 Nov; 209(9):1549-51. PubMed ID: 8899015
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical stimulants of shaking behaviour.
    Wei ET
    J Pharm Pharmacol; 1976 Sep; 28(9):722-3. PubMed ID: 10386
    [No Abstract]   [Full Text] [Related]  

  • 29. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoactive drugs and the organization of behavior.
    Norton S
    Psychopharmacol Bull; 1975 Apr; 11(2):54-5. PubMed ID: 1169793
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modulation by ultralow intensity electromagnetic fields on pharmacologic effects of psychotropic drugs].
    Shtemberg AS; Bazian AS; Shikhov SN; Cherniakov GM; Uzbekov MG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(3):373-7. PubMed ID: 11550647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Method and device for evaluating the emotionally-positive effects of pharmacologic agents].
    Zvartau EE; Petriaevskaia NV; Gutkin NV; Kim VIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1984; 34(4):802-3. PubMed ID: 6495867
    [No Abstract]   [Full Text] [Related]  

  • 33. Interpreting published results of extra-label drug use with special reference to reports of drugs used to correct problem behavior in animals.
    Hart BL; Cliff KD
    J Am Vet Med Assoc; 1996 Oct; 209(8):1382-5. PubMed ID: 8870728
    [No Abstract]   [Full Text] [Related]  

  • 34. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse.
    de Wit H
    NIDA Res Monogr; 1998 Mar; 169():176-87. PubMed ID: 9686416
    [No Abstract]   [Full Text] [Related]  

  • 35. Antidepressant treatment and rodent aggressive behaviour.
    Mitchell PJ
    Eur J Pharmacol; 2005 Dec; 526(1-3):147-62. PubMed ID: 16289453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
    Patkina NA; Evartau EE
    Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preliminary pharmacological assessment of derivatives of isoxazolo[4,3-d]pyrimidine. II.
    Poreba K; Wagner E; Jakowicz I; Balicka D
    Acta Pol Pharm; 1994; 51(4-5):355-8. PubMed ID: 7701950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Special issue on behavioral pharmacology.
    J Exp Anal Behav; 1991 Sep; 56(2):167-423. PubMed ID: 1955809
    [No Abstract]   [Full Text] [Related]  

  • 39. [Behavioral and neurochemical methods in research on new psychotropics].
    Boulu R
    Ann Pharm Fr; 1998; 56(2):54-9. PubMed ID: 9770024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A method for evaluating the zoosocial behavior of rats in psychopharmacology].
    Petrov VI; Grigor'ev IA; Gorbunov SG
    Eksp Klin Farmakol; 1996; 59(4):65-9. PubMed ID: 9026196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.